Something that cannot be denied is the serious impact on industries that the pandemic caused by COVID-19 has left. Yes OK, Pharma industry it has been favored by the demand for products and services aimed at health, it is also facing changes in business models.
The Evaluate report, “Covid-19 Report” pointed out that a part of the industry redistributed its resources to increase the production capacity of medicines to counteract COVID-19 and in the dynamism of research to develop a vaccine. Leaving chronic diseases in the background; in addition, the closeness between the industry and the consumer / patient was damaged by the lack of digitization of the industry, causing delays in diagnosis and care. In an early normalcy, what remains for patients and physicians is to adapt to the digital models of consultations.
With this information it is evident that the pharmaceutical industry has been immersed in the digital irruption. Therefore, it is necessary that brands and their marketing strategies find the ways communication to maintain the dialogue between medical personnel and the final consumer.
Having a clear overview of the impact of the pandemic on the Pharma industry will be crucial to understand the opportunities and challenges that pharmaceutical marketing will have to face, through Whitepaper: Impact of COVID-19 on the Pharma industry strategy, You will have a starting point and reference on the trends and paths that the agencies and members of the pharmaceutical sector will have to travel in the coming months.